Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 3/20 | 0.85 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.85 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.51 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30093157 | 0.96 | CHRNB2 (0.79) | CHRNB2CHRNA4CHRNA7KDM4EALDH1A1 | |
| SCHEMBL6674571 | 0.92 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNA7KDM4EALDH1A1 | |
| SCHEMBL31044635 | 0.92 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNA7KDM4EALDH1A1 | |
| SCHEMBL12195600 | 0.89 | CHRNB2 (0.69) | CHRNB2CHRNA4CHRNA7KDM4EALDH1A1 | |
| SCHEMBL21278464 | 0.88 | CHRNB2 (0.73) | CHRNB2CHRNA4CHRNA7KDM4EALDH1A1 | |
| SCHEMBL6132943 | 0.88 | CHRNB2 (0.73) | CHRNB2CHRNA4CHRNA7KDM4EALDH1A1 | |
| SCHEMBL8348697 | 0.88 | CHRNB2 (0.73) | CHRNB2CHRNA4CHRNA7KDM4EALDH1A1 | |
| SCHEMBL3239914 | 0.88 | CHRNB2 (0.67) | CHRNB2CHRNA4CHRNA7KDM4EALDH1A1 | |
| SCHEMBL20609056 | 0.88 | CHRNB2 (0.67) | CHRNB2CHRNA4CHRNA7KDM4EALDH1A1 | |
| SCHEMBL3460939 | 0.87 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNA7KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9260663-B2 | Liquid crystal composition, liquid crystal display, and method for producing liquid crystal display | JSR CORPORATION (JP) | 2016-02-16 | — | — | US | disclosed |
| US-9260663-B2 | Liquid crystal composition, liquid crystal display, and method for producing liquid crystal display | JSR CORPORATION (JP) | 2016-02-16 | — | — | US | disclosed |
| US-20150092147-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY, AND METHOD FOR PRODUCING LIQUID CRYSTAL DISPLAY | JSR CORPORATION (JP) | 2015-04-02 | — | — | US | disclosed |
| US-20150092147-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY, AND METHOD FOR PRODUCING LIQUID CRYSTAL DISPLAY | JSR CORPORATION (JP) | 2015-04-02 | — | — | US | disclosed |
| US-8124720-B2 | Triazine-based monomeric compound, di-triazine compound, and degradable polymer | NATIONAL CHI NAN UNIVERSITY (TW) | 2012-02-28 | — | — | US | disclosed |
| US-8124720-B2 | Triazine-based monomeric compound, di-triazine compound, and degradable polymer | NATIONAL CHI NAN UNIVERSITY (TW) | 2012-02-28 | — | — | US | disclosed |
| US-20090312520-A1 | Triazine-Based Monomeric Compound, Di-Triazine Compound, and Degradable Polymer | NATIONAL CHI NAN UNIVERSITY (TW) | 2009-12-17 | — | — | US | disclosed |
| US-20090312520-A1 | Triazine-Based Monomeric Compound, Di-Triazine Compound, and Degradable Polymer | NATIONAL CHI NAN UNIVERSITY (TW) | 2009-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090312520-A1 | Triazine-Based Monomeric Compound, Di-Triazine Compound, and Degradable Polymer | CCNB2, CCND2, CCNB1 | CHRNB2 2638/4885CHRNA4 4091/4885CHRNA7 3839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.